WASHINGTON, DC — The Biosimilars Council applauds the unanimous Senate passage of the Affordable Prescriptions for Patients Act led by Senator Cornyn (R-TX) and Senator Blumenthal (D-CT). The bill is aimed at reforming patent abuse in the pharmaceutical industry.“The Biosimilars Council and AAM applauds unanimous Senate passage of the Cornyn-Blumenthal legislation,” said Craig Burton, executive director of the biosimilars council. “Patent thickets are used by brand pharmaceutical companies to maintain high prices and deny patients access to lower-cost medicines. This legislation is a great step in curbing these abuses and will help increase competition and access for biosimilars. We encourage the House to take up this legislation and for Congress to continue working to help lower costs for patients.”
Biosimilars Council applauds patent abuse act
The Biosimilars Council applauds the unanimous Senate passage of the Affordable Prescriptions for Patients Act led by Senator Cornyn (R-TX) and Senator Blumenthal (D-CT). The bill is aimed at reforming patent abuse in the pharmaceutical industry.
Related
Aetna provides $300,000 to Christian Hospital Foundation to support innovative food pharmacy program
The program aims to reduce hospital re-admissions and emergency department visits while creating sustainable pathways to better health.
Peak Rock Capital has completed acquisition of Asembia
Asembia operates the largest national specialty pharmacy conference, the Asembia Specialty Pharmacy Summit, attracting thousands of industry leaders every year.
Acadia Pharmaceuticals appoints Carl Segerstrom as chief people officer
Experienced global HR leader joins Acadia to advance people strategy and support the next phase of growth.
Latest
Survey finds workers unaware of prescription savings programs
A Buzz Health survey shows 94% of employers plan to adopt prescription savings tools, but two-thirds of employees have never been informed about programs to lower medication costs.
Beurer: Studies confirm concentrated heat rapidly reduces insect bite itch without drugs or chemicals
Two Independent investigations totaling more than 12,000 treatments validate thermotherapy as a clinically proven first-line response to mosquito bites
The 'Less Is More' wellness movement comes to toothpaste
Hydroxi Unflavored extends that same philosophy into oral care by pairing advanced dental science with a deliberately minimal formulation.
Retailers accelerate imports ahead of expected tariffs
A new NRF report forecasts record container traffic in July as retailers frontload inventory due to trade uncertainty and potential higher import costs.